Loading...
Loading...
Cellebrite DI Ltd.
Cellebrite DI Ltd.. Spoken Alpha tracks CLBT's earnings calls, guidance changes, and executive accountability over time.
Spoken Alpha tracks CLBT's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters with 70% positive reaction rate
SampleConsistent execution against consensus with the stock following through is the cleanest signal a guidance regime is calibrated. Worth watching for the inflection where execution deteriorates relative to the bar.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for CLBT.
curl https://api.spokenalpha.com/v1/companies/CLBT| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $4.34 | $3.42 | +26.8% | +6.6% | +6.5% |
| Q4 FY2026 | $3.68 | $3.22 | +14.4% | +5.2% | +7.2% |
| Q3 FY2026 | $4.48 | $3.49 | +28.3% | +6.6% | +5.4% |
| Q2 FY2026 | $3.92 | $3.42 | +14.7% | -3.6% | -0.9% |
| Q1 FY2025 | $3.97 | $3.31 | +20.0% | -0.4% | -0.6% |
| Q4 FY2025 | $4.38 | $3.44 | +27.2% | -4.2% | -3.9% |
| Q3 FY2025 | $4.47 | $3.48 | +28.5% | +5.5% | +3.5% |
| Q2 FY2025 | $4.37 | $3.39 | +28.9% | +3.6% | +2.4% |
| Q1 FY2024 | $4.27 | $3.35 | +27.5% | +4.7% | +6.5% |
| Q4 FY2024 | $4.50 | $3.50 | +28.7% | +0.5% | -1.2% |